<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/509"/><api:result><api:object category="publication" id="509" last-affected-when="2024-04-10T20:30:59.37+01:00" last-modified-when="2024-04-10T20:30:59.37+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/509" created-when="2010-05-17T13:46:21.87+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-09-15</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="95294" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033568542" last-modified-when="2024-03-27T15:46:29.943+00:00"><api:citation-count>114</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and α-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or α-fetoprotein. To examine the relationship of the TRA-1-60-defined antigen to similar antigens defined by other monoclonal antibodies, we have carried out comparative Western blot and immunoprecipitation analyses of human GCT-derived cell lines with monoclonal antibodies TRA-1-60, TRA-1-81, GCTM2, and K21. The TRA-1-60 antigen was detected by Western blot analysis in extracts of all human EC cell lines and in clinical specimens of GCT tested as a diffuse band with a molecular weight of &gt;200,000. A similar but noticeably fainter band was detected in GCT composed of seminoma only. The antigen was not expressed by GCT-derived lines without an EC phenotype. Affinity bead-purified TRA-1-60, TRA-1-81, GCTM2 and K21 antigens reacted in Western blot analysis with each of the other antibodies tested, indicating that the epitopes recognized by each antibody are carried by the same molecular species. This molecule could be metabolically labeled with inorganic [35S]sulfate and was degraded by keratanase. Glycopeptides produced from affinity-purified TRA-1-60 antigen by extensive digestion with Pronase exhibited a molecular weight in excess of 10,000 and were degraded by keratanase. The TRA-1-60 epitope was destroyed by digestion with neuraminidase, but the epitopes defined by TRA-1-81, GCTM2, and K21 were not. Our results indicate that human EC cells generally express a cell surface sialylated keratan sulfate proteoglycan that is subject to modification to yield a variety of epitopes, one of which is recognized by the monoclonal antibody TRA-1-60. Sensitivity to milk alkaline digestion suggests that the oligosaccharides of this proteoglycan are O-linked to a core polypeptide.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">21133402400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701355293</api:identifier></api:identifiers></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004745001</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7401615367</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10493530</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Research</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record><api:record format="native" id="509" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10493530" last-modified-when="2020-04-29T04:06:44.31+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and alpha-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or alpha-fetoprotein. To examine the relationship of the TRA-1-60-defined antigen to similar antigens defined by other monoclonal antibodies, we have carried out comparative Western blot and immunoprecipitation analyses of human GCT-derived cell lines with monoclonal antibodies TRA-1-60, TRA-1-81, GCTM2, and K21. The TRA-1-60 antigen was detected by Western blot analysis in extracts of all human EC cell lines and in clinical specimens of GCT tested as a diffuse band with a molecular weight of &gt;200,000. A similar but noticeably fainter band was detected in GCT composed of seminoma only. The antigen was not expressed by GCT-derived lines without an EC phenotype. Affinity bead-purified TRA-1-60, TRA-1-81, GCTM2 and K21 antigens reacted in Western blot analysis with each of the other antibodies tested, indicating that the epitopes recognized by each antibody are carried by the same molecular species. This molecule could be metabolically labeled with inorganic [35S]sulfate and was degraded by keratanase. Glycopeptides produced from affinity-purified TRA-1-60 antigen by extensive digestion with Pronase exhibited a molecular weight in excess of 10,000 and were degraded by keratanase. The TRA-1-60 epitope was destroyed by digestion with neuraminidase, but the epitopes defined by TRA-1-81, GCTM2, and K21 were not. Our results indicate that human EC cells generally express a cell surface sialylated keratan sulfate proteoglycan that is subject to modification to yield a variety of epitopes, one of which is recognized by the monoclonal antibody TRA-1-60. Sensitivity to milk alkaline digestion suggests that the oligosaccharides of this proteoglycan are O-linked to a core polypeptide.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biomedical Science, University of Sheffield, Western Bank, United Kingdom.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10493530</api:text></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Res</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh">Antigens, Surface</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh">Glycopeptides</api:keyword><api:keyword scheme="mesh">Glycoproteins</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Keratan Sulfate</api:keyword><api:keyword scheme="mesh">Lumican</api:keyword><api:keyword scheme="mesh">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Sulfates</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>8</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record><api:record format="native" id="881887" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10493530" last-modified-when="2024-04-09T19:40:33.137+01:00"><api:citation-count>75</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and alpha-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or alpha-fetoprotein. To examine the relationship of the TRA-1-60-defined antigen to similar antigens defined by other monoclonal antibodies, we have carried out comparative Western blot and immunoprecipitation analyses of human GCT-derived cell lines with monoclonal antibodies TRA-1-60, TRA-1-81, GCTM2, and K21. The TRA-1-60 antigen was detected by Western blot analysis in extracts of all human EC cell lines and in clinical specimens of GCT tested as a diffuse band with a molecular weight of &gt;200,000. A similar but noticeably fainter band was detected in GCT composed of seminoma only. The antigen was not expressed by GCT-derived lines without an EC phenotype. Affinity bead-purified TRA-1-60, TRA-1-81, GCTM2 and K21 antigens reacted in Western blot analysis with each of the other antibodies tested, indicating that the epitopes recognized by each antibody are carried by the same molecular species. This molecule could be metabolically labeled with inorganic [35S]sulfate and was degraded by keratanase. Glycopeptides produced from affinity-purified TRA-1-60 antigen by extensive digestion with Pronase exhibited a molecular weight in excess of 10,000 and were degraded by keratanase. The TRA-1-60 epitope was destroyed by digestion with neuraminidase, but the epitopes defined by TRA-1-81, GCTM2, and K21 were not. Our results indicate that human EC cells generally express a cell surface sialylated keratan sulfate proteoglycan that is subject to modification to yield a variety of epitopes, one of which is recognized by the monoclonal antibody TRA-1-60. Sensitivity to milk alkaline digestion suggests that the oligosaccharides of this proteoglycan are O-linked to a core polypeptide.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biomedical Science, University of Sheffield, Western Bank, United Kingdom.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-7215-4410</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1538-7445</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10493530</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh">Sulfates</api:keyword><api:keyword scheme="mesh">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh">Glycopeptides</api:keyword><api:keyword scheme="mesh">Glycoproteins</api:keyword><api:keyword scheme="mesh">Keratan Sulfate</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh">Antigens, Surface</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh">Lumican</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>24</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record><api:record format="native" id="2663805" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1074523691" last-modified-when="2024-03-29T05:57:27.227+00:00"><api:citation-count>111</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>4</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01233644602.08</api:identifier></api:identifiers></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01227677710.49</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01046557135.44</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10493530</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3101 Biochemistry and Cell Biology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">31 Biological Sciences</api:keyword><api:keyword scheme="rcdc">Biotechnology</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh">Antigens, Surface</api:keyword><api:keyword scheme="mesh">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh">Glycopeptides</api:keyword><api:keyword scheme="mesh">Glycoproteins</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Keratan Sulfate</api:keyword><api:keyword scheme="mesh">Lumican</api:keyword><api:keyword scheme="mesh">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh">Proteoglycans</api:keyword><api:keyword scheme="mesh">Sulfates</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>2.03</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record><api:record format="native" id="240654" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000082541600038" last-modified-when="2024-04-10T20:30:59.373+01:00"><api:citation-count>99</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000082541600038&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">235KV</api:identifier><api:identifier scheme="pubmed">10493530</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CANCER RESEARCH</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record><api:record format="native" id="23478" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000082541600038" last-modified-when="2014-07-25T11:03:52.38+01:00"><api:citation-count>59</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Badcock</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Pigott</api:last-name><api:initials>C</api:initials><api:first-names>C</api:first-names><api:separate-first-names><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Goepel</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1930" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1930"/></api:links><api:last-name>Andrews</api:last-name><api:initials>PW</api:initials><api:first-names>PW</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>W</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>18</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CANCER RES</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>GERM-CELL TUMORS</api:keyword><api:keyword>MOLECULAR-WEIGHT GLYCOPROTEINS</api:keyword><api:keyword>DIFFERENTIATION ANTIGENS</api:keyword><api:keyword>MONOCLONAL-ANTIBODIES</api:keyword><api:keyword>TERATOCARCINOMA CELLS</api:keyword><api:keyword>SURFACE ANTIGENS</api:keyword><api:keyword>LINE</api:keyword><api:keyword>SERUM</api:keyword><api:keyword>PATHOGENESIS</api:keyword><api:keyword>EPITOPES</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>4715</api:begin-page><api:end-page>4719</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>59</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antigens, Surface</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Glycopeptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Keratan Sulfate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lumican</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Sulfates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Sulfates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Glycopeptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Keratan Sulfate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antigens, Surface</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lumican</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3101 Biochemistry and Cell Biology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">31 Biological Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biotechnology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antigens, Neoplasm</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antigens, Surface</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Biomarkers, Tumor</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Carcinoma, Embryonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chondroitin Sulfate Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Glycopeptides</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Keratan Sulfate</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lumican</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">N-Acetylneuraminic Acid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Proteoglycans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Sulfates</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword origin="record-data" source="wos">GERM-CELL TUMORS</api:keyword><api:keyword origin="record-data" source="wos">MOLECULAR-WEIGHT GLYCOPROTEINS</api:keyword><api:keyword origin="record-data" source="wos">DIFFERENTIATION ANTIGENS</api:keyword><api:keyword origin="record-data" source="wos">MONOCLONAL-ANTIBODIES</api:keyword><api:keyword origin="record-data" source="wos">TERATOCARCINOMA CELLS</api:keyword><api:keyword origin="record-data" source="wos">SURFACE ANTIGENS</api:keyword><api:keyword origin="record-data" source="wos">LINE</api:keyword><api:keyword origin="record-data" source="wos">SERUM</api:keyword><api:keyword origin="record-data" source="wos">PATHOGENESIS</api:keyword><api:keyword origin="record-data" source="wos">EPITOPES</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3101 Biochemistry and cell biology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0008-5472" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973697" title="Cancer Research"><api:records><api:record source-name="summary"><api:title>Cancer Research</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/509/relationships"/></api:object></api:result></api:response>